Aducanumab and adenoviral COVID-19 vaccines: increased cerebral hemorrhage risk?-Reference-Cited by-同舟云学术

Aducanumab and adenoviral COVID-19 vaccines: increased cerebral hemorrhage risk?

Published:2022-03-28 Issue:4 Volume:22 Page:283-286
ISSN:1473-7175
Container-title:Expert Review of Neurotherapeutics
language:en
Short-container-title:Expert Review of Neurotherapeutics

Author:

MohanaSundaram ArunSundar¹^ORCID,Thukani Sathanantham Shanmugarajan²,Sveikata Lukas³⁴,Lalla Rakesh Shyam⁵,Sveikatienė Renata⁶,Kaushik Ajeet⁷,Velayutham Ravichandiran⁸

Affiliation:

1. School of Pharmacy, Sathyabama Institute of Science and Technology, Chennai, India

2. School of Pharmaceutical Sciences, Vels Institute of Science, Technology and Advanced Studies (VISTAS), Chennai, India

3. Department of Neurology, Massachusetts General Hospital,Harvard Medical School, Boston, Massachusetts, USA

4. Institute of Cardiology, Faculty of Medicine, Lithuanian University of Health Sciences, Kaunas, Lithuania

5. Department of Neurology, Fortis Hospital, Kalyan, India

6. Institute of Physiology and Pharmacology, Faculty of Medicine, Lithuanian University of Health Sciences, Kaunas, Lithuania

7. NanoBioTech Laboratory, Department of Environmental Engineering, Florida Polytechnic University, Lakeland, Florida, USA

8. National Institute of Pharmaceutical Education and Research (NIPER), Kolkata, India

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Neurology (clinical),General Neuroscience

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737175.2022.2053112

Reference21 articles.

1. A contentious FDA ruling for Alzheimer's disease

2. Sveikata L, Charidimou A, Viswanathan A. Vessels sing their ARIAs: the role of vascular amyloid in the age of Aducanumab. Stroke. [Internet] 2021; [cited 2021 Dec 18]. Available from 2021 Dec 18: https://pubmed.ncbi.nlm.nih.gov/34905943/

3. Biogen. Aduhelm (aducanumab-avwa). Highlights of prescribing information. [Internet] 2021; [cited 2021 Dec 18]. Available from 2021 Dec 18: https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761178s000lbl.pdf

4. Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis post COVID-19 vaccination; a systematic review

5. Chen R, Black S. Updated proposed Brighton collaboration process for developing a standard case definition for study of new clinical syndrome X, as applied to thrombosis with thrombocytopenia syndrome (tTS) Atlanta, 2021 Available from:https://brightoncollaboration.us/wp-content/uploads/2021/11/TTS-Updated-Brighton-Collaboration-Case-Defintion-Draft-Nov-11-2021.pdf. Accessed 6 Dec 2021.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glymphotherapeutics for Alzheimer’s disease: Time to move the needle;Ageing Research Reviews;2024-11

2. Unveiling New Strategies Facilitating the Implementation of Artificial Intelligence in Neuroimaging for the Early Detection of Alzheimer’s Disease;Journal of Alzheimer's Disease;2024-04-30

3. Links between COVID-19 and Parkinson’s disease/Alzheimer’s disease: reciprocal impacts, medical care strategies and underlying mechanisms;Translational Neurodegeneration;2023-01-30